Pilot Study of an NTproBNP Guided Strategy of Cardioprotection

Clinical trial NCT04737265 · COMPLETED

Trial details

NCT number: NCT04737265
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cardiotoxicity Toxicity Due to Chemotherapy Breast Cancer Lymphoma Cardiomyopathies Heart Failure

Start date: 2021-03-18
Primary completion: 2025-02-05
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.